检测阴性对照与传统病例对照研究设计在轮状病毒疫苗效果估计偏倚方面的比较
该研究用简单概率模型比较检测阴性对照设计(病例为轮状病毒阳性重症腹泻儿童,对照为阴性儿童)与传统病例对照设计在估计轮状病毒疫苗效果(VE)时的偏倚,在高收入与低收入国家两种情景下考虑检测不完美导致的错分偏倚和疫苗接种影响非轮状病毒腹泻易感性导致的选择偏倚。结果表明两种偏倚均可产生显著偏倚,尤其特异性不完美与严重负偏倚相关;但当前酶免疫法检测灵敏度和特异度均超过99%,且无确凿证据表明现有轮状病毒疫苗影响非轮状病毒腹泻率,故作者认为检测阴性对照设计是估计轮状病毒VE的便捷可靠替代方法。
要点
- 检测阴性对照设计以轮状病毒阳性重症腹泻儿童为病例、阴性儿童为对照。
- 模型显示检测不完美与疫苗接种影响非轮状病毒腹泻均可导致VE估计显著偏倚。
- 当前酶免疫法检测灵敏度和特异度均超过99%,支持检测阴性对照设计可靠。
核心结论
- 检测阴性对照研究设计是估计轮状病毒疫苗效果的便捷可靠替代方法。
研究设计与样本
- 使用简单概率模型比较检测阴性对照设计与传统病例对照设计在估计轮状病毒疫苗效果时的偏倚,在高收入国家和低收入国家两种情景下进行。
主要发现
- 若诊断试验特异度为90%,两种病例对照研究设计的VE估计可能低估真实VE超过20%。
- 若疫苗保护儿童免于非轮状病毒腹泻,即使真实VE为50%,检测阴性对照研究的VE估计可能接近零。
- 当前用于诊断轮状病毒感染的酶免疫法检测灵敏度和特异度均超过99%,且无确凿证据表明现有轮状病毒疫苗影响非轮状病毒腹泻率。
关键数值与推荐
- 诊断试验特异度为90%时,两种病例对照研究设计的VE估计可能低估真实VE超过20%。
- 疫苗保护儿童免于非轮状病毒腹泻时,检测阴性对照研究的VE估计可能接近零,即使真实VE为50%。
- 当前酶免疫法检测诊断轮状病毒感染的灵敏度和特异度均超过99%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Estimation of the effectiveness of rotavirus vaccines via the test-negative control study design has gained popularity over the past few years. In this study design, children with severe diarrhea who test positive for rotavirus infection are considered as cases, while children who test negative serve as controls. We use a simple probability model to evaluate and compare the test-negative control and the traditional case-control designs with respect to the bias of resulting estimates of rotavirus vaccine effectiveness (VE). Comparisons are performed under two scenarios, corresponding to studies performed in high-income and low-income countries. We consider two potential sources of bias: (a) misclassification bias resulting from imperfect sensitivity and specificity of the test used to diagnose rotavirus infection, and (b) selection bias associated with possible effect of rotavirus vaccination on the probability of contracting severe non-rotavirus diarrhea. Our results suggest that both sources of bias may produce VE estimates with substantial bias. Particularly, lack of perfect specificity is associated with severe negative bias. For example, if the specificity of the diagnostic test is 90% then VE estimates from both types of case-control studies may under-estimate the true VE by more than 20%. If the vaccine protects children against non-rotavirus diarrhea then VE estimates from test-negative control studies may be close to zero even though the true VE is 50%. However, the sensitivity and specificity of the enzyme immunoassay test currently used to diagnose rotavirus infections are both over 99%, and there is no solid evidence that the existing rotavirus vaccines affect the rates of non-rotavirus diarrhea. We therefore conclude that the test-negative control study design is a convenient and reliable alternative for estimation of rotavirus VE.
引用
- Haber M, Lopman BA, Tate JE, et al. A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness. Vaccine. 2018. PMID: 29980389. doi:10.1016/j.vaccine.2018.06.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。